Quarterly report · Q3
2796.TEDINET S100T8YK
Period2023-06-01 → 2024-02-29
Filed2024-04-10
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 36
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥40.7bn | 2023-06-01 → 2024-02-29 | Cons. | Net sales |
| Revenue | ¥52.0bn | 2022-06-01 → 2023-05-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥38.7bn | 2022-06-01 → 2023-02-28 | Cons. | Net sales |
| Operating income | ¥863m | 2023-06-01 → 2024-02-29 | Cons. | Operating income |
| Operating income | ¥896m | 2022-06-01 → 2023-02-28 | Cons. | Operating income |
| Ordinary income | ¥799m | 2023-06-01 → 2024-02-29 | Cons. | Ordinary income |
| Ordinary income | ¥1.4bn | 2022-06-01 → 2023-05-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥890m | 2022-06-01 → 2023-02-28 | Cons. | Ordinary income |
| Profit before tax | ¥761m | 2023-06-01 → 2024-02-29 | Cons. | Income before income taxes |
| Profit before tax | ¥722m | 2022-06-01 → 2023-02-28 | Cons. | Income before income taxes |
| Net income (owners) | ¥177m | 2023-06-01 → 2024-02-29 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥333m | 2022-06-01 → 2023-05-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥208m | 2022-06-01 → 2023-02-28 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥187m | 2023-06-01 → 2024-02-29 | Cons. | Profit loss |
| Net income | ¥218m | 2022-06-01 → 2023-02-28 | Cons. | Profit loss |
| Total assets | ¥26.4bn | at 2024-02-29 | Cons. | Assets |
| Total assets | ¥23.4bn | at 2023-05-31 | Cons. | Assets |
| Total assets | ¥22.9bn | at 2023-02-28 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥18.5bn | at 2024-02-29 | Cons. | Liabilities |
| Total liabilities | ¥16.4bn | at 2023-05-31 | Cons. | Liabilities |
| Net assets / equity | ¥8.0bn | at 2024-02-29 | Cons. | Net assets |
| Net assets / equity | ¥7.0bn | at 2023-05-31 | Cons. | Net assets |
| Net assets / equity | ¥6.8bn | at 2023-02-28 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥5.2bn | at 2024-02-29 | Cons. | Cash and deposits |
| Cash and deposits | ¥4.7bn | at 2023-05-31 | Cons. | Cash and deposits |
| EPS (basic) | ¥17.22 | 2023-06-01 → 2024-02-29 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-8.42 | 2023-12-01 → 2024-02-29d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥35.45 | 2022-06-01 → 2023-05-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥22.24 | 2022-06-01 → 2023-02-28 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥14.45 | 2022-12-01 → 2023-02-28d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥16.48 | 2023-06-01 → 2024-02-29 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥26.89 | 2022-06-01 → 2023-05-31 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥16.89 | 2022-06-01 → 2023-02-28 | Cons. | Diluted earnings per share (5-year summary) |
| Equity ratio | 29.0% | at 2024-02-29 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 28.5% | at 2023-05-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 28.4% | at 2023-02-28 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 44
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2023-06-01 → 2024-02-29 | ¥593m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2023-06-01 → 2024-02-29 | ¥593m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2023-06-01 → 2024-02-29 | ¥5m |
| Reconciling Itemsreconciling | segment profit | 2023-06-01 → 2024-02-29 | −¥250m |
| jpcrp040300-q3r_E05379-000Cosmetic Drug And Convenience Storereportable segment | revenue | 2023-06-01 → 2024-02-29 | ¥6.2bn |
| jpcrp040300-q3r_E05379-000Cosmetic Drug And Convenience Storereportable segment | revenue external | 2023-06-01 → 2024-02-29 | ¥6.2bn |
| jpcrp040300-q3r_E05379-000Cosmetic Drug And Convenience Storereportable segment | segment profit | 2023-06-01 → 2024-02-29 | −¥45m |
| jpcrp040300-q3r_E05379-000Custody Of Medical Documentsreportable segment | revenue | 2023-06-01 → 2024-02-29 | ¥456m |
| jpcrp040300-q3r_E05379-000Custody Of Medical Documentsreportable segment | revenue external | 2023-06-01 → 2024-02-29 | ¥456m |
| jpcrp040300-q3r_E05379-000Custody Of Medical Documentsreportable segment | segment profit | 2023-06-01 → 2024-02-29 | ¥33m |
| jpcrp040300-q3r_E05379-000Dispensing Pharmacyreportable segment | revenue | 2023-06-01 → 2024-02-29 | ¥33.1bn |
| jpcrp040300-q3r_E05379-000Dispensing Pharmacyreportable segment | revenue external | 2023-06-01 → 2024-02-29 | ¥33.1bn |
| jpcrp040300-q3r_E05379-000Dispensing Pharmacyreportable segment | segment profit | 2023-06-01 → 2024-02-29 | ¥1.0bn |
| jpcrp040300-q3r_E05379-000Medical Mallreportable segment | revenue | 2023-06-01 → 2024-02-29 | ¥378m |
| jpcrp040300-q3r_E05379-000Medical Mallreportable segment | revenue external | 2023-06-01 → 2024-02-29 | ¥378m |
| jpcrp040300-q3r_E05379-000Medical Mallreportable segment | segment profit | 2023-06-01 → 2024-02-29 | ¥83m |
| —segment total | revenue | 2023-06-01 → 2024-02-29 | ¥40.1bn |
| —segment total | revenue external | 2023-06-01 → 2024-02-29 | ¥40.1bn |
| —segment total | segment profit | 2023-06-01 → 2024-02-29 | ¥1.1bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2023-06-01 → 2024-02-29 | ¥40.7bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2023-06-01 → 2024-02-29 | ¥40.7bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2023-06-01 → 2024-02-29 | ¥1.1bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2022-06-01 → 2023-02-28 | ¥573m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2022-06-01 → 2023-02-28 | ¥573m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2022-06-01 → 2023-02-28 | ¥37m |
| Reconciling Itemsreconciling | segment profit | 2022-06-01 → 2023-02-28 | −¥226m |
| jpcrp040300-q3r_E05379-000Cosmetic Drug And Convenience Storereportable segment | revenue | 2022-06-01 → 2023-02-28 | ¥5.8bn |
| jpcrp040300-q3r_E05379-000Cosmetic Drug And Convenience Storereportable segment | revenue external | 2022-06-01 → 2023-02-28 | ¥5.8bn |
| jpcrp040300-q3r_E05379-000Cosmetic Drug And Convenience Storereportable segment | segment profit | 2022-06-01 → 2023-02-28 | −¥170m |
| jpcrp040300-q3r_E05379-000Custody Of Medical Documentsreportable segment | revenue | 2022-06-01 → 2023-02-28 | ¥485m |
| jpcrp040300-q3r_E05379-000Custody Of Medical Documentsreportable segment | revenue external | 2022-06-01 → 2023-02-28 | ¥485m |
| jpcrp040300-q3r_E05379-000Custody Of Medical Documentsreportable segment | segment profit | 2022-06-01 → 2023-02-28 | ¥56m |
| jpcrp040300-q3r_E05379-000Dispensing Pharmacyreportable segment | revenue | 2022-06-01 → 2023-02-28 | ¥31.5bn |
| jpcrp040300-q3r_E05379-000Dispensing Pharmacyreportable segment | revenue external | 2022-06-01 → 2023-02-28 | ¥31.5bn |
| jpcrp040300-q3r_E05379-000Dispensing Pharmacyreportable segment | segment profit | 2022-06-01 → 2023-02-28 | ¥1.1bn |
| jpcrp040300-q3r_E05379-000Medical Mallreportable segment | revenue | 2022-06-01 → 2023-02-28 | ¥378m |
| jpcrp040300-q3r_E05379-000Medical Mallreportable segment | revenue external | 2022-06-01 → 2023-02-28 | ¥378m |
| jpcrp040300-q3r_E05379-000Medical Mallreportable segment | segment profit | 2022-06-01 → 2023-02-28 | ¥70m |
| —segment total | revenue | 2022-06-01 → 2023-02-28 | ¥38.2bn |
| —segment total | revenue external | 2022-06-01 → 2023-02-28 | ¥38.2bn |
| —segment total | segment profit | 2022-06-01 → 2023-02-28 | ¥1.1bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-06-01 → 2023-02-28 | ¥38.7bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-06-01 → 2023-02-28 | ¥38.7bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2022-06-01 → 2023-02-28 | ¥1.1bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 396
| Item | Context | Value | Unit |
|---|---|---|---|
| Loss on sales of noncurrent assets el | CurrentYTDDuration | 0 | JPY |
| Loss on retirement of noncurrent assets el | Prior1YTDDuration | 31000000 | JPY |
| Loss on retirement of noncurrent assets el | CurrentYTDDuration | 4000000 | JPY |
| Impairment loss el | Prior1YTDDuration | 46000000 | JPY |
| Impairment loss el | CurrentYTDDuration | 16000000 | JPY |
| Loss on reduction of noncurrent assets el | Prior1YTDDuration | 61000000 | JPY |
| Loss on reduction of noncurrent assets el | CurrentYTDDuration | 35000000 | JPY |
| Provision of allowance for doubtful accounts el | Prior1YTDDuration | － | JPY |
| Provision of allowance for doubtful accounts el | CurrentYTDDuration | 41000000 | JPY |
| Loss on cancellation of leasehold contracts el | Prior1YTDDuration | 104000000 | JPY |
| Loss on cancellation of leasehold contracts el | CurrentYTDDuration | 3000000 | JPY |
| Extraordinary loss | Prior1YTDDuration | 248000000 | JPY |
| Extraordinary loss | CurrentYTDDuration | 100000000 | JPY |
| Income before income taxes | Prior1YTDDuration | 722000000 | JPY |
| Income before income taxes | CurrentYTDDuration | 761000000 | JPY |
| Income taxes | Prior1YTDDuration | 503000000 | JPY |
| Income taxes | CurrentYTDDuration | 573000000 | JPY |
| Profit loss | Prior1YTDDuration | 218000000 | JPY |
| Profit loss | CurrentYTDDuration | 187000000 | JPY |
| Profit loss attributable to non controlling interests | Prior1YTDDuration | 9000000 | JPY |
| Profit loss attributable to non controlling interests | CurrentYTDDuration | 10000000 | JPY |
| Profit loss attributable to owners of parent | Prior1YTDDuration | 208000000 | JPY |
| Profit loss attributable to owners of parent | CurrentYTDDuration | 177000000 | JPY |
| Profit loss | Prior1YTDDuration | 218000000 | JPY |
| Profit loss | CurrentYTDDuration | 187000000 | JPY |
| Valuation difference on available for sale securities net of tax oci | Prior1YTDDuration | 0 | JPY |
| Valuation difference on available for sale securities net of tax oci | CurrentYTDDuration | 0 | JPY |
| Remeasurements of defined benefit plans net of tax oci | Prior1YTDDuration | -0 | JPY |
| Remeasurements of defined benefit plans net of tax oci | CurrentYTDDuration | -1000000 | JPY |
| Other comprehensive income | Prior1YTDDuration | -0 | JPY |
| Other comprehensive income | CurrentYTDDuration | -0 | JPY |
| Comprehensive income | Prior1YTDDuration | 217000000 | JPY |
| Comprehensive income | CurrentYTDDuration | 187000000 | JPY |
| Comprehensive income attributable to owners of the parent | Prior1YTDDuration | 208000000 | JPY |
| Comprehensive income attributable to owners of the parent | CurrentYTDDuration | 176000000 | JPY |
| Comprehensive income attributable to non controlling interests | Prior1YTDDuration | 9000000 | JPY |
| Comprehensive income attributable to non controlling interests | CurrentYTDDuration | 10000000 | JPY |
| Revenues from external customers | Prior1YTDDuration_jpcrp040300-q3r_E05379-000DispensingPharmacyReportableSegmentsMember | 31532000000 | JPY |
| Revenues from external customers | Prior1YTDDuration_jpcrp040300-q3r_E05379-000CosmeticDrugAndConvenienceStoreReportableSegmentsMember | 5760000000 | JPY |
| Revenues from external customers | Prior1YTDDuration_jpcrp040300-q3r_E05379-000CustodyOfMedicalDocumentsReportableSegmentsMember | 485000000 | JPY |
| Revenues from external customers | Prior1YTDDuration_jpcrp040300-q3r_E05379-000MedicalMallReportableSegmentsMember | 378000000 | JPY |
| Revenues from external customers | Prior1YTDDuration_ReportableSegmentsMember | 38156000000 | JPY |
| Revenues from external customers | Prior1YTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | 573000000 | JPY |
| Revenues from external customers | Prior1YTDDuration_TotalOfReportableSegmentsAndOthersMember | 38730000000 | JPY |
| Revenues from external customers | Prior1YTDDuration_ReconcilingItemsMember | － | JPY |
| Revenues from external customers | Prior1YTDDuration | 38730000000 | JPY |
| Transactions with other segments | Prior1YTDDuration_jpcrp040300-q3r_E05379-000DispensingPharmacyReportableSegmentsMember | － | JPY |
| Transactions with other segments | Prior1YTDDuration_jpcrp040300-q3r_E05379-000CosmeticDrugAndConvenienceStoreReportableSegmentsMember | － | JPY |
| Transactions with other segments | Prior1YTDDuration_jpcrp040300-q3r_E05379-000CustodyOfMedicalDocumentsReportableSegmentsMember | － | JPY |
| Transactions with other segments | Prior1YTDDuration_jpcrp040300-q3r_E05379-000MedicalMallReportableSegmentsMember | － | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 12 of 12 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |